These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31713232)
21. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus. Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446 [TBL] [Abstract][Full Text] [Related]
22. Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany. Kortland LM; Alfter A; Bähr O; Carl B; Dodel R; Freiman TM; Hubert K; Jahnke K; Knake S; von Podewils F; Reese JP; Runge U; Senft C; Steinmetz H; Rosenow F; Strzelczyk A Epilepsia; 2016 Dec; 57(12):2056-2066. PubMed ID: 27753082 [TBL] [Abstract][Full Text] [Related]
23. Treatment of refractory generalized convulsive status epilepticus with enteral topiramate in resource limited settings. Asadi-Pooya AA; Jahromi MJ; Izadi S; Emami Y Seizure; 2015 Jan; 24():114-7. PubMed ID: 25458103 [TBL] [Abstract][Full Text] [Related]
24. Topiramate in refractory epilepsy: a prospective observational study. Stephen LJ; Sills GJ; Brodie MJ Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624 [TBL] [Abstract][Full Text] [Related]
25. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective. Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354 [TBL] [Abstract][Full Text] [Related]
26. [Expression of multidrug resistance gene and topiramate affect expression of multidrug resistance gene in the hippocampus of spontaneous epileptic rats]. Jin RF; Sun RP; Xu XP Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):733-7. PubMed ID: 16255849 [TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study. Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834 [TBL] [Abstract][Full Text] [Related]
28. Factors associated with occurrence and outcome of super-refractory status epilepticus. Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934 [TBL] [Abstract][Full Text] [Related]
29. Influence of new versus traditional antiepileptic drugs on course and outcome of status epilepticus. Reindl C; Sprügel MI; Sembill JA; Mueller TM; Hagen M; Gerner ST; Kuramatsu JB; Hamer HM; Huttner HB; Madžar D Seizure; 2020 Jan; 74():20-25. PubMed ID: 31790940 [TBL] [Abstract][Full Text] [Related]
30. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres. García-Ruiz M; Rodríguez PM; Palliotti L; Lastras C; Romeral-Jiménez M; Morales IG; Rey CP; Rodrigo-Gisbert M; Campos-Fernández D; Santamarina E; Carbonell BP Seizure; 2024 Apr; 117():13-19. PubMed ID: 38301485 [TBL] [Abstract][Full Text] [Related]
31. Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany. Kortland LM; Knake S; von Podewils F; Rosenow F; Strzelczyk A Front Neurol; 2017; 8():507. PubMed ID: 29018404 [TBL] [Abstract][Full Text] [Related]
32. Oral topiramate as an add-on treatment for refractory status epilepticus. Stojanova V; Rossetti AO Acta Neurol Scand; 2012 Feb; 125(2):e7-e11. PubMed ID: 21711264 [TBL] [Abstract][Full Text] [Related]
33. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387 [TBL] [Abstract][Full Text] [Related]
34. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study. Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243 [TBL] [Abstract][Full Text] [Related]
35. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy. Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980 [TBL] [Abstract][Full Text] [Related]
36. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats. Reissmüller E; Ebert U; Löscher W Epilepsia; 2000 Apr; 41(4):372-9. PubMed ID: 10756400 [TBL] [Abstract][Full Text] [Related]
37. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy. Borowicz KK; Luszczki JJ; Duda AM; Czuczwar SJ Epilepsia; 2003 May; 44(5):640-6. PubMed ID: 12752462 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review. Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209 [TBL] [Abstract][Full Text] [Related]
39. Responsive neurostimulation as a treatment for super-refractory focal status epilepticus: a systematic review and case series. Ernst LD; Raslan AM; Wabulya A; Shin HW; Cash SS; Yang JC; Sagi V; King-Stephens D; Damisah EC; Ramos A; Hussain B; Toprani S; Brandman DM; Shahlaie K; Kanth K; Arain A; Peters A; Rolston JD; Berns M; Patel SI; Uysal U J Neurosurg; 2024 Jan; 140(1):201-209. PubMed ID: 37329518 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of topiramate in children with refractory status epilepticus. Kahriman M; Minecan D; Kutluay E; Selwa L; Beydoun A Epilepsia; 2003 Oct; 44(10):1353-6. PubMed ID: 14510830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]